Calcium-sensing receptor and calcimimetic agents

Kidney International, Supplement

Volumn 56, Issue 73, 1999, Pages

  Coburn, Jack W ^a,b   Elangovan, Loganathan ^a   Goodman, William G ^a   Frazaõ, Joaõ M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Nephrology Section (1111)   (United States)

Author keywords

Blood ionized calcium; Parathyroid carcinoma; Primary hyperparathyroidism; Secondary hyperparathyroidism

Indexed keywords

CALCIUM CHANNEL STIMULATING AGENT; CALCIUM ION; CALCIUM SENSING RECEPTOR; MAGNESIUM; R 568; SODIUM; UNCLASSIFIED DRUG; WATER; ANILINE DERIVATIVE; CALCIUM; CELL SURFACE RECEPTOR; N (2 CHLOROPHENYLPROPYL) 1 (3 METHOXYPHENYL)ETHYLAMINE; N-(2-CHLOROPHENYLPROPYL)-1-(3-METHOXYPHENYL)ETHYLAMINE; PARATHYROID HORMONE;

ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM HOMEOSTASIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; HUMAN; HYPERCALCEMIA; HYPOPARATHYROIDISM; MINERAL METABOLISM; NONHUMAN; PARATHYROID CARCINOMA; PARATHYROID HORMONE RELEASE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; ANIMAL; BLOOD; DRUG POTENTIATION; HYPERPARATHYROIDISM; KIDNEY; METABOLISM; PARATHYROID GLAND; PHYSIOLOGY; REVIEW;

ANILINE COMPOUNDS; ANIMALS; CALCIUM; HUMANS; HYPERPARATHYROIDISM; KIDNEY; PARATHYROID GLANDS; PARATHYROID HORMONE; RECEPTORS, CALCIUM-SENSING; RECEPTORS, CELL SURFACE;

EID: 0033372296     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.07303.x     Document Type: Article

References (43)

1. 2+ and other ions as extracellular (first) messengers. Physiol Rev 71:371-411, 1991
2. 2+-sensing receptor from bovine parathyroid. Nature 366:575-580, 1993
3. PEARCE SHS, TRUMP D, WOODING C, BESSER CM, CHEW SL, GRANT DB, HEATH DA, HUGHES IA, PATERSON CR, WHYTE MP, THAKKER RV: Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest 96:2683-2692, 1995
4. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe-hyperparathroidism. Cell 75:1297-1303, 1993
5. POLLAK MR, SEIDMAN CE, BROWN EM: Three inherited disorders of calcium sensing. Medicine (Balt) 75:115-123, 1996
6. 2+-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Human Mol Genet 5:601-606, 1996
7. PEARCE SHS, WILLIAMSON C, KIFOR O, BAI M, COULTHARD MG, DAVIES M, LEWIS-BARNED N, MCCREDIE D, POWELL H, KENDALL-TAYLOR P, BROWN EM, THAKKER RV: A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335:1115-1122, 1996
8. 2+ receptor expressed in Xenopus laevis oocytes by NPS 467 or NPS 568. Mol Pharmacol 53:1083-1088, 1998
9. BROWN EM, POLLAK M, HEBERT SC: The extracellular calcium-sensing receptor: Its role in health and disease. Annu Rev Med 49:15-29, 1998
10. HEBERT SC: Extracellular calcium-sensing receptor: Implications for calcium and magnesium handling in the kidney. Kidney Int 50:2129-2139, 1996
11. BROWN EM: Physiology and pathophysiology of the extracellular calcium-sensing receptor. Am J Med 106:238-253, 1999
12. CHOLST IN, STEINBERG SF, TROPPER PJ, FOX HE, SEGRE GV, BILEZIKIAN JP: The influence of hypermagnesemia on serum calcium and parathyroid hormone in human subjects. N Engl J Med 310:1221-1225, 1984
13. QUAMME GA: Effect of hypercalcemia on renal tubular handling of calcium and magnesium. Can J Physiol Pharmacol 60:1275-1280, 1982
14. QUAMME GA: Control of magnesium transport in the thick ascending limb. Am J Physiol 256:F197-F210, 1989
15. BROWN EM, HEBERT SC: Calcium-receptor-regulated parathyroid and renal function. Bone 20:303-309, 1997
16. 2+/polyvalent cation-sensing protein in rat kidney. Am J Physiol 274:F611-F622, 1998
17. SANDS JM, NARUSE M, BAUM M, Jo I, HEBERT SC, BROWN EM, HARRIS HW: Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest 99:1399-1405, 1997
18. 3 by calcium in the parathyroidectomized, parathyroid hormone-replete rat. J Bone Miner Res 4:929-935, 1989
19. 2+-sensing receptor in rat intestine. Am J Physiol 274:G122-G130, 1998
20. ROGERS KV, DUNN CK, HEBERT SC, BROWN EM: Localization of calcium receptor mRNA in the adult rat central nervous system by in situ hybridization. Brain Res 744:47-56, 1997
21. HOUSE MG, KOHLMEIER L, CHATTOPADHYAY N, KIFOR O, YAMAGUCHI T, LEBOFF MS, GLOWACKI J, BROWN EA: Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J Bone Miner Res 12:1959-1970, 1997
22. i signaling expresed by GCT23 osteoclast-like cells. Proc Assoc Am Phys 111:70-81, 1999
23. QUARLES LD: Cation sensing receptors in bone: a novel paradigm for regulating bone remodeling? J Bone Miner Res 12:1971-1974, 1997
24. POLLAK MR, CHOU Y-HW, MARX SJ, STEINMANN B, COLE DEC, BRANDI ML, PAPAPOULOS SE, MENKO FH, HENDY GN, BROWN EM, SEIDMAN CE, SEIDMAN JG: Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effect of mutant gene dosage on phenotype. J Clin Invest 93:1108-1112, 1994
25. MARX SJ, ATTIE MF, STOCK JL, SPIEGEL AM, LEVINE MA: Maximal urine-concentrating ability: Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J Clin Endocrinol Metab 52:736-740, 1981
26. HEATH DA: Familial hypocalciuric hypercalcemia, in The Parathryoids, edited by BILEZIKIAN JP, LEVTNE MA, MARCUS R, New York, Raven Press, Ltd., 1994, pp 699-710
27. HO C, CONNOR DA, POLLAK MR, LADD DJ, KIFOR O, WARREN HB, BROWN EM, SEIDMAN JG, SEIDMAN CE: A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 11:389-394, 1995
28. 2+-sensing receptor gene: Normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 99:88-96, 1997
29. 2+-sensing receptor gene mutation. Nat Genet 8:303-307, 1994
30. HEATH D: Familial hypocalcemia - Not hypoparathyroidism. N Engl J Med 335:1144-1145, 1996
31. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Emdocrinol Metab 81:1598-1606, 1996
32. GOGUSEV J, DUCHAMBON P, HORY B, GIOVANNINI M, GOUREAU Y, SARFATI E, DRÜEKI:, TB: Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 51:328-336, 1997
33. 3 Endocrinology 136:499-504, 1995
34. BROWN AJ, ZHONG M, FINCH J, RITTER C, MCCRACKEN R, MORRISEY J, SLATOPOLSKY E: Rat calcium sensing receptor is regulated by vitamin D but not by calcium. Am J Physiol 270:F454-F460, 1996
35. 2+ receptor mRNA and protein increase in the rat parathyroid gland with advancing age. J Endocrinol 153:437-444, 1997
36. MATHIAS RS, NGUYEN HT, ZHANG MYH, PORTALE AA: Reduced expression of the renal calcium-sensing receptor in rats with experimental chronic renal insufficiency. J Am Soc Nephrol 9:2067-2074, 1998
37. NEMETH EF, STEFFEY ME, HAMMERLAND LG, HUNG BC, VAN WAGENEN BC, DELMAR EG, BALANDRIN MF: Calcimimeties with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 95:4040-4045, 1998
38. NEMETH EF, BENNETT SA: Tricking the parathyroid gland with novel calcimimetic agents. Nephrol Dial Transplant 13:1923-1925, 1999
39. WADA M, FURUYA Y, SAKIYAMA J-I: The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. J Clin Invest 100:2977-2983, 1997
40. WADA M, ISHII H, FURUYA Y, FOX J, NEMETH EF, NAGANO N: NPS R-568 halts or reverses osteitis fibrosa in uremic rats. Kidney Int 53:448-453, 1998
41. SILVERBERG SI, BONE H, MARRIOT T, LOCKER FG, THYS-JACOBS S, DZIEM G, KAATZ S, SANGUINETTI EL, BILEZIKIAN JP: Short-term inhibition of parathyroid hormone secretion by a calcium receptor agonist in primary hyperparathyroidism. N Engl J Med 337:1506-1510, 1997
42. ANTONSEN JE, SHERRARD DJ, ANDRESS DL: A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Kidney Int 53:510-511, 1998
43. COLLINS MT, SKARULIS MC, BILEZIKIAN JP, SILVERBERG SJ, SPIEGEL AM, MARKS SJ: Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J Clin Endocrinol Metab 83:1083-1088, 1998